HSBC HOLDINGS PLC - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 125 filers reported holding IMMUNOVANT INC in Q1 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q4 2022$862,421
+21.1%
49,592
-61.6%
0.00%0.0%
Q3 2022$712,000
+46.5%
129,289
+5.6%
0.00%0.0%
Q2 2022$486,000
-21.0%
122,420
+11.4%
0.00%0.0%
Q1 2022$615,000
-32.3%
109,939
+4.6%
0.00%0.0%
Q4 2021$909,000
+78.2%
105,073
+83.4%
0.00%0.0%
Q3 2021$510,000
+39.3%
57,288
+625.3%
0.00%
Q4 2020$366,000
-23.9%
7,899
-39.8%
0.00%
-100.0%
Q3 2020$481,000
-21.8%
13,120
-48.1%
0.00%0.0%
Q2 2020$615,000
+37.6%
25,273
-12.1%
0.00%0.0%
Q1 2020$447,00028,7420.00%
Other shareholders
IMMUNOVANT INC shareholders Q1 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,717,182$139,213,0003.92%
Ghost Tree Capital, LLC 525,000$12,784,0003.37%
Logos Global Management LP 625,000$15,219,0003.04%
ACUTA CAPITAL PARTNERS, LLC 350,000$8,523,0002.46%
BVF INC/IL 1,088,479$26,504,0001.63%
Vivo Capital, LLC 800,000$19,480,0001.40%
Camber Capital Management LP 800,000$19,480,0001.12%
Sio Capital Management, LLC 152,450$3,712,0001.08%
Prosight Management, LP 95,500$2,325,0001.00%
Parkman Healthcare Partners LLC 125,125$3,047,0000.86%
View complete list of IMMUNOVANT INC shareholders